The CEO & Director General of The King Hussein Cancer Center
Asem H. Mansour, M.D., has served as the CEO and Director General of Jordan’s King Hussein Cancer Center (KHCC), the largest standalone comprehensive cancer center in the Middle East, since 2012. In this role, he leads over 3,000 staff members, including 400 oncologists and consultants, to execute KHCC’s vision of providing the highest quality care to cancer patients throughout the region.
Dr. Mansour’s affiliation with KHCC dates back to 1998, when he was appointed Chairman of the Department of Diagnostic Radiology, and subsequently led the department to become one of the most advanced diagnostic imaging facilities in the Kingdom, with highly qualified staff and state-of-the-art machinery.
In 2006, he became KHCC’s Deputy Director General and was promoted in early 2012 to be the Center's Director General and the Executive Chairman of the Jordan Breast Cancer Program (JBCP), a national program concerned with activating early detection of breast cancer by improving the quality of services provided across Jordan.
He also serves as an active Board Member of the Union for International Cancer Control (UICC), having been elected for a second term from 2024 to 2026 and a Board Member of the Union for International Cancer Control (UICC). Furthermore, he has held the position of Commissioner for the Lancet Commission on Cancer & Health Systems since 2022.
Since he assumed leadership of KHCC, he has worked tirelessly to shape and direct the strategic vision, provide the optimum portfolio of services while capitalizing on recent advancements and successes in the fields of Cancer Care, Oncology Training and Research which ultimately positioned KHCC as a leading oncology center in the region and as international hub sought from around the world. The Center’s reputation for quality, innovation, and clinical excellence today draws over 6,000 new cancer patients from Jordan and internationally each year.
Dr. Mansour’s breadth of experience has been paramount to the success of KHCC. He led the nursing and the quality management teams to achieve status as one of the ten most elite international hospitals, and the first Oncology Specialized Center outside the United States to earn the prestigious Magnet® distinction from the American Nurses Credentialing Center (ANCC) in 2019. Under his leadership, KHCC also became an AHAARP (Association for the Accreditation of Human Research Protection Programs) accredited academic institution in 2019, placing it as one of the top performing research institutions in the Middle East.
A renowned Diagnostic Radiologist with a subspecialty fellowship in Neuroradiology (ESNR), Dr. Mansour earned his M.D. from the Vitebsk Medical Institute, School of Medicine. He completed a fellowship with the Royal College of Radiologists (FRCR- London), and holds a Master’s of Medical Management (MMM) from Carnegie Mellon University in the United States. In 2022, the American Association of Physicians Leadership (AAPL) named him a Certified Physician Executive (CPE), and he received his M.Sc. in International Public Health from Liverpool John Moores University in 2023.
Moreover, he is an accomplished, published author of the famous, controversial, debut book “Two Years of Solitude”, published in 2021. He is also an editor, a columnist, an active reviewer, who co-authored over 90 peer-reviewed publications. He coauthored two eBooks published in Frontiers in Medicine entitled “Bioethics amidst the COVID-19 Pandemic” in 2022 and another in 2023 entitled as “Cancer care in areas of conflict”.
In October 2024, Dr. Mansour was awarded the Kuwait Prize for the Control of Cancer, Cardiovascular Diseases, and Diabetes in the Eastern Mediterranean Region in recognition of his exceptional contributions to Cancer Care.